Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stalevo versus Sinemet Plus in Parkinson's disease with wearing-off
2006-000680-28Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Stalevo arm with Sinemet Plus arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started May 2006; status: completed.
02
Drugs
levodopacarbidopa + levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2006-000680-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000680-28.